Metabolism of 1,1-dichloro-2,2,2-trifluoroethane in rats

References

• Boocaard P. J., Commandeur J. N. M., Mulder G. J., Vermeulen N. P. E., Nagelkerke J. F. Toxicity of the cysteine-S-conjugates and mercapturic acids of four structurally related difluoroethylenes in isolated proximal tubular cells from rat kidney. Biochemical Pharmacology 1989; 38: 3731–3741
   PubMed Web of Science ®Google Scholar
• Bruschi S. A., West K., Crabb J. W., Stevens J. L. Mitochondrial P1 (cpn60) is a major target protein for modification by reactive metabolites of S-(1,1,2,2-tetrafluoroethyl)-L-cysteine (TFEC). Toxicologist 1993; 13: 231
   Google Scholar
• Chen Q., Yu K., Stevens J. L. Regulation of the cellular stress response by reactive electrophiles. Journal of Biological Chemistry 1992; 267: 24322–24327
   PubMed Web of Science ®Google Scholar
• Cohen E. N., Trudell J. R., Edmunds H. N., Watson E. Urinary metabolites of halothane in man. Anesthesiology 1975; 43: 392–401
   PubMed Web of Science ®Google Scholar
• Commandeur J. N. M., Brakenhoff J. P. G., Kanter F. J. J., Vermeulen N. P. E. Nephrotoxicity of mercapturic acids of three structurally related 2,2-difluoroethylenes in the rat-indications for different bioactivation mechanisms. Biochemical Pharmacology 1988; 37: 4495–4504
   PubMed Web of Science ®Google Scholar
• Commandeur J. N. M., Oostendorp R. A. J., Schoofs P. R., Xu B., Vermeulen N. P. E. Nephrotoxicity and hepatotoxicity of 1,1-dichloro-2,2-difluoroethylene in the rat. Biochemical Pharmacology 1987; 36: 4229–4237
   PubMed Web of Science ®Google Scholar
• Dallmeier E., Henschler D. Halothan-Belastung am Arbeitsplatz im Operatioinssaal. Experimentelle Begründung für biologisches Monitoring und Aufstellung eines Grenzwertes. Deutsche medizinische Wochenschrift 1981; 106: 324–328
   PubMed Web of Science ®Google Scholar
• Dekant W., Lash L. H., Anders M. W. Bioactivation mechanism of the cytotoxic and nephrotoxic S-conjugate S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine. Proceedings of the National Academy of Sciences, USA 1987a; 84: 7443–7447
   PubMed Web of Science ®Google Scholar
• Dekant W., Martens G., Vamvakas S., Metzler M., Henschler D. Bioactivation of tetrachloroethylene-role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alleviation. Drug Metabolism and Disposition 1987b; 15: 702–709
   PubMed Web of Science ®Google Scholar
• Dekant W., Vamvakas S., Anders M. W. Biosynthesis, bioactivation, and mutagenicity of S-conjugates. Toxicology Letters 1990; 53: 53–58
   PubMed Web of Science ®Google Scholar
• Dekant W., Vamvakas S., Anders M. W. The kidney as a target organ for xenobiotics bioactivated by glutathione conjugation. Tissue Specific Toxicity: Biochemical Mechanisms, W. Dekant, H.-G. Neumann. Academic, London 1992; 163–194
   Google Scholar
• Fisher D. A., Hales C. H., Filkin D. L., Ko M. K. W., Sze N. D., Connell P. S., Wuebbles D. J., Isaksen I. S. A., Stordal F. Model calculations of the relative effects of CFCs and their replacements on stratospheric ozone. Nature 1990; 344: 508–512
   Web of Science ®Google Scholar
• Gargas M. L., Clewell H. J., Andersen M. E. Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways. Toxicology and Applied Pharmacology 1986; 82: 211–223
   PubMed Web of Science ®Google Scholar
• Harris J. W., Anders M. W. In vivo metabolism of the hydrochlorofluorocarbon 1,1-dichloro-1-fluoroethane (HCFC-141b). Biochemical Pharmacology 1991; 41: R13–16
   PubMed Web of Science ®Google Scholar
• Harrip J. W., Pohl L. R., Martin J. L., Anders M. W. Tissue acylation by the chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123). Proceedings of the National Academy of Sciences, USA 1991; 88: 1407–1410
   PubMed Web of Science ®Google Scholar
• Kassahun K., Baillie T. A. Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparations. Drug Metabolism and Disposition 1993; 21: 242–248
   PubMed Web of Science ®Google Scholar
• Malley L. A., Carakostas M. C., Hansen J. F., Trochimowicz H. J., Rusch G. M. Chronic toxicity of hydrochlorofluorocarbon HCFC-123. Toxicologist 1991; 11: 103
   Google Scholar
• Malley L. A., Trochimowicz H. J., Rusch G. M., Carakostas M. C., Hansen J. F. Subchronic toxicity of HCFC-123 in rats. Toxicologist 1990; 10: 205
   Google Scholar
• McFarland M., Kaye J. Chlorofluorocarbons and ozone. Photochemistry and Photobiology 1992; 55: 911–929
   PubMed Web of Science ®Google Scholar
• Müller R., Stier A. Modification of liver microsomal lipids by halothane metabolites: a multi nuclear NMR spectroscopic study. Naunyn-Schmiedeberg's Archives of Pharmacology 1982; 321: 234–237
   PubMed Web of Science ®Google Scholar
• Olson M. J., Johnson J. T., O'Gara J. F., Surbrook S. E. J. Metabolism in vivo and in vitro of the refrigerant substitute 1,1,1,2-tetrafluoro-2-chloroethane. Drug Metabolism and Disposition 1991a; 19: 1004–1011
   PubMed Web of Science ®Google Scholar
• Olson M. J., Kim S. G., Reidy C. A., Johnson J. T., Novak R. F. Oxidation of 1,1,1,2-tetrafluoroethane in rat liver microsomes is catalyzed primarily by cytochrome P-450IIE1. Drug Metabolism and Disposition 1991b; 19: 298–303
   PubMed Web of Science ®Google Scholar
• Olson M. J., Surbrook S. E. J. Defluorination of the CFC-substitute 1,1,1,2-tetrafluoroethane: comparison in human, rat and rabbit hepatic microsomes. Toxicology Letters 1991; 59: 89–99
   PubMed Web of Science ®Google Scholar
• Reichert D., Werner H. W., Metzler M., Henschler D. Molecular mechanisms of 1,1-dichloroethylene toxicity: excreted metabolites reveal different pathways of reactive intermediates. Archives of Toxicology 1979; 42: 159–169
   PubMed Web of Science ®Google Scholar
• Rowland F. S. Ozone depletion theory. Science 1993; 261: 1101–1103
   PubMed Web of Science ®Google Scholar
• Surbrook S. E. J., Olson M. J. Dominant role of cytochrome P-450 2E1 in human hepatic microsomal oxidation of the CFC-substitute 1,1,1,2-tetrafluoroethane. Drug Metabolism and Disposition 1992; 20: 518–524
   PubMed Web of Science ®Google Scholar
• Urban G., Speerschneider P., Dekant W. Metabolism of the chlorofluorocarbon-substitute 1,1-dichloro-2,2,2-trifluoroethane by rat and human liver microsomes: the role of cytochrome P-450 IIE1. Chemical Research in Toxicology 1994; 7: 170–177
   PubMed Web of Science ®Google Scholar